Highlights: GLP-1 receptor agonists linked to 14 percent lower risk of developing substance use disorders Reduce

MONDAY, March 9, 2026 -- The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use...

MONDAY, March 9, 2026 -- The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use...

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say...

A new study suggests drugs such as Ozempic and Wegovy may help alleviate symptoms of anxiety and depression, with semaglutide linked to significantly...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...

The blockbuster GLP-1 drugs that reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce their...